Allied Market Research
Upcoming Allied Market Research
Vitiligo Drugs Market

Vitiligo Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022-2029

Pages: NA
Jul 2022 | 507 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Vitiligo Drugs Market

Request Now !

Vitiligo is a hypopigmentation skin disorder characterized by the white patches on the skin that causes the loss of skin color due to low concentration of melanin in the skin cells. It affects the skin on all parts of the body, hair and inside of the mouth. Vitiligo is not life threatening disorder, however it is found in the people with dark skin and it affected people may feel stressful and have issues about their appearance. The common symptoms of vitiligo include the whitening of the skin and development of white patches on the skin anywhere on the body. Vitiligo disorder found in the age of 40. The exact cause of vitiligo is not known. The researcher found that it is an autoimmune disorder, in which the person’s own immune system falsely acts against the skin cells which produces melanin. Treatment for vitiligo can restore the color to the affected spot on the skin. However, it cannot completely prevent skin discoloration. “Vitiligo Society” in Europe providing the funds for research projects with developing effective and safe treatments for patients and establishing the real causes of vitiligo as well. 


Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value ($USD)

  Segments covered

  By Treatment, Type, Route of Administration, Distribution Channel

  Region covered

North America (U.S., Canada), Europe (U.K, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and Rest of Asia-Pacific), LANTAM (Brazil, Mexico, Argentina and Rest of Latin America), Middle East & Africa (South Africa, Suadi Arabia and UAE)

  Companies covered

Major players analyzed include, Dermavant Sciences, Inc., Incyte Corporation, Aclaris Therapeutics, Inc., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Bristol - Myers Squibb, Pfizer, Inc., Clinuvel Pharmaceuticals Ltd., Applied Biology, Inc., Boston Pharmaceuticals, F. Hoffmann-La Roche AG, Pfizer, Inc. Sanofi S.A, Teva Pharmaceutical Industries, Mylan NV, Aurobindo Pharma Limited, Eli Lilly and Company, Bausch Health Companies, Inc.


COVID-19 Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

 As the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries across the globe with the “World Health Organization” announcing it a public health emergency. The global impacts of the COVID-19 pandemic are already starting to be felt, and will significantly affect the vitiligo drugs market in 2020. COVID-19 can affect the global economy in three main ways by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally, North America market contributes for the largest market share for Vitiligo Treatment and dominate overall market. This attributed to the factors including, increasing incidence of skin disorder such as vitiligo, increasing adoption rate of phototherapy treatment and rising investment in healthcare facilities.  However, Europe is considered as the second large market share for vitiligo treatment due to the presence of major market player, rising investment in research and development activities with the undergoing severe clinical trial. Whereas,  Asia Pacific is anticipated to expand the vitiligo drug market due to the rising government funding, growing adoption rate of new technology and drug and increasing medical tourism in countries. 

In 2019, “American Skin Association” (ASA) declared funding for 18 new grants for skin cancer and disease research. The ASA and its affiliates invested over US$ 50 million for the treatment of melanoma, psoriasis, and vitiligo. “American Academy of Dermatology” reported that in 2017, around150,000 patient were treated for vitiligo during 2013 in the U.S. and also announced that Vitiligo is listed among 24 skin diseases. “National Center for Biotechnology Information” (NCBI), in 2017, approximately 0.5-1% of the global population was diagnosed with vitiligo and 8.8% of India’s population was diagnosed with vitiligo.

The factors such as increasing incidence of vitiligo disorder, changing lifestyle, rising awareness among the individuals, availability of appropriate treatment, Government undertaken initiatives to develop novel treatments for vitiligo, increasing development of new novel therapy and drug discovery, increasing clinical trial studies for launching new drug. Rising demand for the vitiligo treatment, increasing R&D activities are drive the growth of vitiligo drug market. However, the factors which restrain the growth of vitiligo treatment market such as high cost of treatment and stringent regulation for the drug development. The major opportunities available for vitiligo drug market includes, increasing investment in R&D for developing new drug, rising launch of new product therapy, increasing awareness among the individuals and presence of favorable government policies. 

New Product launch to flourish the market:

Major Key market manufacturer have been focusing on increasing research and development activities and producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. At present, there is no cure for vitiligo however, some drugs help restore the skin tone. Topical corticosteroids are prescribed as first-line treatment for vitiligo and inflammatory disease and It help in regain skin color. Other drug product such as tacrolimus or pimecrolimus, are used in the treatment of individuals who experience comparatively small areas of depigmentation

In 2017, “Aclaris Therapeutics, Inc.” has introduce “Confluence Life Sciences, Inc.”, a company focused on development of kinase inhibitors for the treatment of autoimmune disorders such as alopecia areata, vitiligo, and atopic dermatitis.

In 218, “Aclaris Therapeutics, Inc.”, has launched “ATI 502” is a topically administered inhibitor of janus kinase (JAK), that is being developed for the treatment of alopecia areata, atopic dermatitis, androgenetic alopecia, and vitiligo.

In 2019, "Dr Reddy's Laboratories” has launched “Melgain lotion”, a patented drug approved for treatment of vitiligo. It is effectively used in combination with other treatment methods for best results. It lightens the skin by increasing the elimination of melanin from skin cells.

In 2018, “STRATA Skin Sciences”, has launched “XTRAC S3 308nm Laser”. This is used for the treatment of skin disorders such as psoriasis and vitiligo. The XTRAC laser utilizes therapeutic UVB light for the treatment of affected skin areas without damaging surrounding healthy skin.

Key segments covered:



  By Treatment

  • Drug Class (Calcineurin Inhibitor, Corticosteroids, Psoralens)
  • Therapy (Depigmentation, Light Therapy)


  • Surgery (Skin grafting, Blister grafting, Micro pigmentation)


  • Segmental
  • Non Segmental

  Route of Administration

  • Oral Route
  • Topical Route

  Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies


Key benefits of the report:

  • This study presents the analytical depiction of the global vitiligo drugs market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global vitiligo drugs market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global vitiligo drugs market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global vitiligo drugs market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Vitiligo Drugs Market research report:

  • Who are the leading market player’s active in vitiligo drugs market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the vitiligo drugs market?
  • What are the projections for the future that will help in taking further strategic steps?

Key Market Segments

Segments Sub-segments
By Treatment
  • Drug Class
  • Therapy
  • Surgery
By Type
  • Segmental
  • Non Segmental
By Route of Administration
  • Oral Route
  • Topical Route
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players

  • Dermavant Sciences, Inc.
  • Incyte Corporation
  • Aclaris Therapeutics, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc
  • Bristol - Myers Squibb
  • Pfizer, Inc.
  • Clinuvel Pharmaceuticals Ltd.
  • Applied Biology, Inc.
  • Boston Pharmaceuticals
  • F. Hoffmann-La Roche AG
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Vitiligo Drugs Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers